Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ankur Rohilla

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 17, 2009
The infarct size-limiting effect of ischemic postconditioning (IPOC) is suppressed in isolated hyperhomocysteinemic (Hhcy) rat hearts: the reasonable role of PKC-deltaAnkur Rohilla, Pitchai Balakumar
Current Drug Discovery Technologies|April 17, 2024
Drug Repositioning: A Monetary Stratagem to Discover a New Application of DrugsAnkur Rohilla, Seema Rohilla
Pharmacological Research|November 25, 2010
Pleiotropic actions of fenofibrate on the heartPitchai Balakumar, Ankur Rohilla, Nanjaian Mahadevan
Archives of Pharmacal Research|October 7, 2011
Myocardial postconditioning: next step to cardioprotectionAnkur Rohilla, Seema Rohilla, Ashok Kushnoor
Pharmacological Research|July 1, 2008
Pre-conditioning and postconditioning to limit ischemia-reperfusion-induced myocardial injury: what could be the next footstep?Pitchai Balakumar, Ankur Rohilla, Manjeet Singh
Pharmacological Research|May 4, 2010
Gentamicin-induced nephrotoxicity: Do we have a promising therapeutic approach to blunt it?Pitchai Balakumar, Ankur Rohilla, Arunachalam Thangathirupathi
Journal of Advanced Pharmaceutical Technology & Research|October 12, 2012
Cardioprotective potential of simvastatin in the hyperhomocysteinemic rat heartAnkur Rohilla, M U Khan, Razia Khanam
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 8, 2009
Possible role of JAK-2 in attenuated cardioprotective effect of ischemic preconditioning in hyperhomocysteinemic rat heartsGurfateh Singh, Ankur Rohilla, Manjeet Singh, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 17, 2009
Possible involvement of PKC-delta in the abrogated cardioprotective potential of ischemic preconditioning in hyperhomocysteinemic rat heartsAnkur Rohilla, Gurfateh Singh, Manjeet Singh, et al.
European Journal of Pharmacology|July 2, 2015
A comparative study on the cardioprotective potential of atorvastatin and simvastatin in hyperhomocysteinemic rat heartsAnkur Rohilla, Ayaz Ahmad, M U Khan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 17, 2009
The infarct size-limiting effect of ischemic postconditioning (IPOC) is suppressed in isolated hyperhomocysteinemic (Hhcy) rat hearts: the reasonable role of PKC-deltaAnkur Rohilla, Pitchai Balakumar
Current Drug Discovery Technologies|April 17, 2024
Drug Repositioning: A Monetary Stratagem to Discover a New Application of DrugsAnkur Rohilla, Seema Rohilla
Pharmacological Research|November 25, 2010
Pleiotropic actions of fenofibrate on the heartPitchai Balakumar, Ankur Rohilla, Nanjaian Mahadevan
Archives of Pharmacal Research|October 7, 2011
Myocardial postconditioning: next step to cardioprotectionAnkur Rohilla, Seema Rohilla, Ashok Kushnoor
Pharmacological Research|July 1, 2008
Pre-conditioning and postconditioning to limit ischemia-reperfusion-induced myocardial injury: what could be the next footstep?Pitchai Balakumar, Ankur Rohilla, Manjeet Singh
Pharmacological Research|May 4, 2010
Gentamicin-induced nephrotoxicity: Do we have a promising therapeutic approach to blunt it?Pitchai Balakumar, Ankur Rohilla, Arunachalam Thangathirupathi
Journal of Advanced Pharmaceutical Technology & Research|October 12, 2012
Cardioprotective potential of simvastatin in the hyperhomocysteinemic rat heartAnkur Rohilla, M U Khan, Razia Khanam
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 8, 2009
Possible role of JAK-2 in attenuated cardioprotective effect of ischemic preconditioning in hyperhomocysteinemic rat heartsGurfateh Singh, Ankur Rohilla, Manjeet Singh, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 17, 2009
Possible involvement of PKC-delta in the abrogated cardioprotective potential of ischemic preconditioning in hyperhomocysteinemic rat heartsAnkur Rohilla, Gurfateh Singh, Manjeet Singh, et al.
European Journal of Pharmacology|July 2, 2015
A comparative study on the cardioprotective potential of atorvastatin and simvastatin in hyperhomocysteinemic rat heartsAnkur Rohilla, Ayaz Ahmad, M U Khan, et al.
Pageof 2